Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics

Virulence. 2012 Nov 15;3(7):592-4. doi: 10.4161/viru.22364. Epub 2012 Nov 15.
No abstract available

Keywords: alternative therapeutics; mannosides; two-component systems; type 1 pili; urinary tract infection; uropathogenesis; virulence gene regulation.

Publication types

  • Comment

MeSH terms

  • Animals
  • Escherichia coli Proteins / metabolism*
  • Female
  • Fimbriae, Bacterial / metabolism*
  • Urinary Tract Infections / microbiology*
  • Uropathogenic Escherichia coli / metabolism*

Substances

  • Escherichia coli Proteins